baber/WOPTO huggingface dataset:
Patent NZ-571840-A (NZ)
Title: All natural grease filter formed of wool fiber with soy, whey, or linseed solution
Inventor: RANDINELLI TODD
IPC: B01D39/04
Filed: 2007-04-20
Abstract: An all natural filter assembly (100) without toxic materials for use in an air filtration unit is disclosed. The filter assembly for use in an air filtration unit includes a support frame (110) and a disposable grease filter (120) disposed across said support frame. The disposable grease filter is formed of wool fiber coated with a bonding agent comprising a natural soy, whey and/or linseed solution.
Patent NZ-580828-A (NZ)
Title: Antibodies against clostridium difficile toxin B and uses thereof
Inventor: AMBROSINO DONNA
IPC: C12N5/06
Filed: 2005-02-04
Abstract: Discloses is an isolated human monoclonal antibody or antigen binding portion there that specifically binds to Clostridium defficile toxin B. The invention further discloses compositions comprising said antibody and uses thereof for the production of a medicament for treating a C. defficile disease.
Patent NZ-581742-A (NZ)
Title: Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
Inventor: LIU CHUNYU
IPC: C12Q1/68
Filed: 2008-06-06
Abstract: Disclosed is a method of predicting the response of a subject to a therapy comprising an anti-TNF agent, the method comprising: providing a biological sample obtained from a subject that has an immune disorder; and measuring the expression level of at least five genes selected from the group consisting of CLTB (SEQ ID NO: 10), COL4A3BP (SEQ ID NO: 11), CXorf52 (SEQ ID NO: 12), FAM44A (SEQ ID NO: 16), MXRA7 (SEQ ID NO: 22), PGKI (SEQ ID NO: 25), SFRS2 (SEQ ID NO: 32) and YIPF6 (SEQ ID NO: 36) in the biological sample, wherein at least five of (i) an elevated expression level, as compared to a healthy individual, of CLTB (SEQ ID NO: 10), COL4A3BP (SEQ ID NO: 11), PGKI (SEQ ID NO: 25), or YIPF6 (SEQ ID NO: 36), or (ii) a reduced expression level, as compared to a healthy individual, of CXorf52 (SEQ ID NO: 12), FAM44A (SEQ ID NO: 16), MXRA7 (SEQ ID NO: 22), or SFRS2 (SEQ ID NO: 32) predicts that the subject will respond to a therapy comprising an anti-TNF agent.
Patent NZ-583337-A (NZ)
Title: Synergistic mixtures of chlorantraniliprole and a macrocyclic lactone selected from spinosad, avermectin, doramectin, emamectin, eprinomectin, ivermectin, milbemectin, milbemycin oxime, moxidectin, nemadectin and selamectin
Inventor: SELBY THOMAS PAUL
IPC: A01N43/16
Filed: 2005-06-30
Abstract: Disclosed is a mixture for controlling an invertebrate pest (such as silverleaf whitefly (Bemisia argentifolii), western flower thrip (Frankliniella occidentalis), potato leafhopper (Empoasca fabae), corn plant hopper (Peregrinus maidis), cotton melon aphid (Aphis gossypii), green peach aphid (Myzus persicae), beet armyworm (Spodoptera exigua), cabbage looper (Trichoplusia ni) and diamondback moth (Plutella xylostella)) which comprises: (a) a compound of formula I, which is 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (chlorantraniliprole), an N-oxide, or a salt thereof, and a component (b) wherein the component (b) is a macrocyclic lactone selected from the group consisting of spinosad, avermectin, doramectin, emamectin, eprinomectin, ivermectin, milbemectin, milbemycin oxime, moxidectin, nemadectin and selamectin; and their salts.
Patent NZ-584725-A (NZ)
Title: 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
Inventor: BOUILLOT ANNE MARIE JEANNE
IPC: C07D413/12
Filed: 2008-11-07
Abstract: Disclosed are substituted triazole compounds of formula (I), salts thereof, and methods for their preparation. Specific examples of triazoles of formula (I) are: N-[3,4-bis(methyloxy)phenyl]-1-[(4-fluorophenyl)methyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide 1-[(4-Fluorophenyl)methyl]-5-methyl-N-{ 4-[(phenylmethyl)oxy]phenyl} -1H-1,2,3-triazole-4-carboxamide, 1-[3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide 1-[(3,4-Dichlorophenyl)methyl]-N-(3-{ [(2-hydroxyethyl)amino]carbonyl} phenyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide, and N-[3,5-bis(hydroxymethyl)phenyl]-5-methyl-1-(phenylmethyl)-1H-1,2,3-triazole-4-carboxamide The compounds of formula (I) are useful for treating a disease susceptible to amelioration by an SCD inhibitor, and are also useful for treating diseases caused by an abnormal plasma lipid profile, peripheral vascular disease, reperfusion injury, angioplastic restenosis, hypertension, vascular complications of diabetes, thrombosis, hepatic steatosis, non-alcoholic steatohepatitis (NASH) and other diseases related to accumulation of lipids in the liver; eczema, acne, psoriasis, skin ageing, keloid scar formation or prevention, and diseases related to production or secretions from mucous membranes; cancer, neoplasia, malignancy, metastases, tumours (benign or malignant), carcinogenesis, hepatomas and the like; mild cognitive impairment (MCI), Alzheimer's Disease (AD), cerebral amyloid angiopathy (CAA) or dementia associated with Down Syndrome (OS) and other neurodegenerative diseases characterized by the formation or accumulation of amyloid plaques comprising Amyloid BETA 42 (A[beta]42).
Patent NZ-586378-A (NZ)
Title: Solution preparation containing antibody at high concentration
Inventor: MORICHIKA TOSHIYUKI
IPC: A61K9/08
Filed: 2008-12-26
Abstract: Disclosed is a stable antibody-containing liquid formulation comprising 40 to 1000 mM arginine and 10 to 200mM methionine. Further disclosed is a method for inhibiting dimerization of molecules of an antibody in a liquid formulation containing the antibody, comprising adding arginine and methionine to the liquid formulation.
Patent NZ-587885-A (NZ)
Title: Joint for connecting pipes that allows rotational and longitudinal movement of the pipes relative to each other
Inventor: HOBBS ANDREW
IPC: E03C1/12
Filed: 2010-09-10
Abstract: Disclosed is a swivel joint assembly for coupling two tubular plumbing conduits to each other in flow communication with each other and which permits angular movement and axial expansion of the conduits relative to each other, allowing easier connection. The assembly includes a tubular swivel joint member having one swivel joint formation, a tubular adaptor including a complementary swivel joint formation that is complementary to the one swivel joint formation. The one swivel joint formation on the tubular swivel joint member is one of a spigot or socket formation and the complementary swivel joint formation on the adaptor is the other of a spigot or socket formation. A displaceable tubular member is telescopically coupled such that it is in flow communication to the tubular adaptor. One of the displaceable tubular member and the tubular adapter is an inner tubular member and the other of the inner tubular member and the tubular adapter is an outer tubular member. The inner tubular member is slidingly received within the outer tubular member such that the tubular adapter and the tubular member are telescopically displaceable relative to each other whereby to render the joint assembly axially expansible as well as capable of a swivelling action. A socket retainer is used for retaining the socket formation on the swivel joint member or the adaptor in its operative position mounted over the spigot formation. The socket retainer including a collar, concentrically surrounds the spigot formation and is spaced radially outward of the spigot formation. A retaining shoulder on the collar extends radially inward from one end to a radially inner edge that defines a socket opening which is sized to receive an adjacent portion of the socket formation therein but resists the entire socket formation from being withdrawn.
Patent NZ-591391-A (NZ)
Title: Non-invasive methods for treating eye disorders using a topical oligonucleotide composition
Inventor: FEINSTEIN ELENA
IPC: A61K31/711
Filed: 2009-10-22
Abstract: Disclosed is a double strand RNA compound having the structure: 5'iB GCCAGAAUGUGGAACUCCU 3' (sense strand) 3' CGGUCUUACACCUUGAGGA 5' (antisense strand) Wherein each nucleotide is a ribonucleotide and each consecutive ribonucleotide is joined to the next ribonucleotide by a phosphodiester bond; And wherein the sense strand comprises an L-deoxycytidine at position 18, and an inverted abasic 5' cap, and the antisense strand comprises a 2'-O-Me sugar modified ribonucleotide at positions 2, 4, 6, 8, 11, 13, 15, 17 and 19. Further disclosed is the use of said compound in the preparation of a medicament for treating a patient suffering from an ocular disease, an ocular disorder, an ocular injury, a visual field loss, or for providing ocular neuroprotection.
Patent NZ-593245-A (NZ)
Title: Inhaler with means to pierce a compartment containing medication
Inventor: SAWANT RAJESH
IPC: A61M15/00
Filed: 2009-11-09
Abstract: Disclosed is an inhaler device for dispensing doses of medicament. The inhaler has means for receiving a compartment (42) containing medicament. Medicament extraction facilitating means locate medicament in a received compartment and thereby allow extraction of medicament from the compartment. The extraction facilitating means comprises (i) a first fluid pathway extending therethrough for directing extracted medicament to an outlet (114) of the inhaler and (ii) means which, in use, provides a second fluid pathway for directing fluid into the compartment past a sealing material of the compartment pierced by the extraction facilitating means.
Patent NZ-594696-A (NZ)
Title: An arrangement for automatically cleaning teat cups of a rotary milking platform
Inventor: ERIKSSON JAN
IPC: A01J7/02
Filed: 2010-03-26
Abstract: The disclosure relates to an arrangement for automatically cleaning teat cups (7) of a rotary milking platform (2). The platform (2) comprises a plurality of milking stall (3) provided with teat cups (7). The arrangement comprises a cleaning device (10) arranged on a radially outer or inner side of the platform (2) which is adapted to clean at least the teat cups (7) in the milking stalls.
Patent NZ-596045-A (NZ)
Title: Container, for mixing medicaments, with partitioning plug and stopper with a thorough hole through both through which passes a driving rod
Inventor: WU KUO CHENG
IPC: A61J1/05
Filed: 2011-10-27
Abstract: A container 1, comprises a body having an opening on one end thereof, as well as a closed end on the other end, at least one partitioning plug 2 disposed in the body to divide the body into at least two chambers, where each of the at least one partitioning plug 2 has a through-hole 21, a stopper 3 disposed at the opening of the body and having a through-hole 33, and a driving rod 4 equipped with at least one blocking portion 41 movably engaged in the through-hole or through-holes of the at least one partitioning plug 2. One end of the driving rod 4 protrudes from the opening of the body.
Patent NZ-598833-A (NZ)
Title: Antimicrobial and wound-healing action pharmaceutical composition for external application process of producing the same
Inventor: DUSHKIN ALEKSANDR VALEREVICH
IPC: A61P31/04
Filed: 2011-05-11
Abstract: Disclosed herein is an antimicrobial and wound-healing pharmaceutical composition which comprises fosfomycin and a finely dispersed nanostructured silica dioxide, wherein the composition is formulated for external administration, and wherein the fosfomicin and the finely dispersed nanostructured silica dioxide are present in a weight ratio of (25-75) : (75-25), wherein the size of finely dispersed nanostructured silica dioxide particles is equal to or less than 5 microns and is present in an amount not less than 40% of the total weight of the composition.
Patent NZ-599577-A (NZ)
Title: Substituted benzamide derivatives
Inventor: GROEBKE ZBINDEN KATRIN
IPC: A61K31/4025
Filed: 2010-12-17
Abstract: The disclosure relates to substituted benzamide derivatives of formula I wherein R; R1; n; o; p; R2; Y; R’’ and q are as defined in the specification or to a pharmaceutically suitable acid addition salt thereof. It has now been found that the compounds of formula I have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinsons disease, neurodegenerative disorders such as Alzheimers disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadian rhythm, and cardiovascular disorders. compounds of the disclosure include: (RS)-4-chloro-N-(5-piperidin-3-yl)pyridin-2-yl)benzamide hydrochloride, (RS)-3-(2-Chloro-phenyl)-N-(4-pyrrolidin-3-yl-phenyl)-propionamide, (RS)-2-(4-Chloro-phenyl)-N-(4-pyrrolidin-3-yl-phenyl)-acetamide, (S)-4-chlorobenzyl-4-(piperidin-3-yl)phenylcarbamate, (S)-N-(4-(1,4-Oxazepan-2-yl)phenyl)-3-chlorobenzamide, (RS)-2-Ethoxy-N-(4-(morpholin-2-yl)phenyl)isonicotinamide, (RS)-N-(4-(Morpholin-2-yl)phenyl)-2-(pyrazin-2-yl)thiazole-4-carboxamide, and (RS)-5-Chloro-pyrazine-2-carboxylic acid (4-piperidin-3-yl-phenyl)-amide
Patent NZ-601658-A (NZ)
Title: Cycloalkyl-substituted imidazole derivative
Inventor: NOGUCHI KENGO
IPC: A61K31/4164
Filed: 2011-03-14
Abstract: Compounds represented by general formula (I) wherein A represents a C3-12 cycloalkyl group optionally substituted by 1-3 substituents selected from among fluoro groups, hydroxide groups and/or a C1-6 alkyl groups; R1, R2 and R3 each individually represents a hydrogen atom, a fluoro group or a C1-6 alkyl group; R4 represents a hydrogen atom or a prodrug group;and Y represents -CH2-CHR5-CH2-NHR6, in which R5 represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group and R6 represents a hydrogen atom or a prodrug group and pharmacologically-acceptable salts thereof exhibit a TAFIa-inhibiting activity, and thus are useful as therapeutic drugs for myocardial infarction, angina, acute coronary syndrome, cerebral infarction, deep vein thrombosis, pulmonary embolism.
Patent NZ-602051-A (NZ)
Title: Device for simultaneous attachment and folding of brackets for roofing sheet
Inventor: SVANBERG BJARNE
IPC: E04D3/362
Filed: 2011-03-17
Abstract: 602051 A device for simultaneous attachment of a bracket for roofing sheet to an underlay and folding of at least a part of an end portion of a connecting tongue of the bracket into a low flange of plate or sheet coverage, where the device comprises a housing 1, at a first end of which is arranged a fixed or detachably mounted driving apparatus 3 and at a second end of which is arranged a hollow means 5, which is axially displaceable relative to the housing 1 and which projects beyond the second end 4 of the housing 1. The projecting end of the hollow means 5 is provided with a folding device 10 comprising a pivotable folding arm 11 having a first end 11a. The device further comprises an actuation means 6 arranged at the second end 4 of the housing 1, the actuation means 6 arranged for giving a radial motion to the first end 11a of the folding arm 11 thereby axially displacing the housing 1 and the folding device 10 against each other, so that the first end 11a of the folding arm 11 folds into the low flange the at least a part of an end portion of the connecting tongue of the bracket, is mounted in the folding device, while the bracket is being attached to the underlay.
Patent NZ-602139-A (NZ)
Title: Plant peptide gamma-zein for delivery of biomolecules into plant cells
Inventor: SAMBOJU NARASIMHA CHARY
IPC: C12N15/29
Filed: 2011-03-08
Abstract: Disclosed is a method of introducing a nucleic acid of interest into a plant cell having a cell wall, the method comprising: providing the plant cell having a cell wall; interacting a gamma-zein peptide with a nucleic acid of interest to form a gamma-zein linked structure; placing the cell having a cell wall and the gamma-zein linked structure in contact with each other; and allowing uptake of the gamma-zein linked structure into the cell having the cell wall.
Patent NZ-604678-A (NZ)
Title: Wind/water turbine with rotational resistance reduced by wind vane blade
Inventor: TAMATSU YOSHIJI
IPC: F03B7/00
Filed: 2011-06-07
Abstract: 604678 A vertical axis type wind/water turbine mainly consists of rotationally symmetric vanes which are secured at both ends thereof to supporting plates, the vane being made up of several blades, the blade having one vertical side being attached to a blade rotating shaft, the other free side being individually allowed to rotate freely in the shape of a sector between both the adjacent blade rotating shafts. When the vane of the wind/water turbine is convex against a wind/water flow, the blades are pushed and opened by the wind/water flow to reduce rotational resistance. When the vane is further rotated to be concave, the blades block between the blade rotating shafts and allow the entire face of the vane to be subjected to a wind/water pressure, providing a high rotational force with the rotational resistance reduced. To avoid risk, the foot of all the blades can be only wound around or retreated to the blade rotating shaft to make the horizontal sides of the blade shorter than the interval between both the adjacent blade rotating shafts. This allows the blades to freely rotate 360 degrees about the blade rotating shaft to lose the rotational force of the wind/water turbine, thereby significantly reducing the overall resistance and thus making it possible to avoid risk.
Patent NZ-614217-A (NZ)
Title: Diagnostic antibody assay
Inventor: KLEINSCHMIDT MARTIN
IPC: G01N33/68
Filed: 2012-03-16
Abstract: Discloses a monoclonal antibody, characterised in that it binds to Aβ peptides starting with amino acid 11 and having a pyroglutamate at the N-terminus (AβpGlu(11)) with high affinity, wherein said high affinity means a dissociation constant (KD) value of 10-7 M or better and wherein said antibody is antibody Aβ 13-11-6, which is produced by hybridoma cell line with Deposit No. DSM ACC3100, or a humanised or chimeric antibody or an antibody fragment thereof. Also discloses use of the antibody to treat or diagnose neurodegenerative diseases.
Patent NZ-617921-A (NZ)
Title: Construction frame shear lug
Inventor: MONTAGUE EMORY L
IPC: E04B1/41
Filed: 2009-10-29
Abstract: An anchorage assembly 210 within a foundation, the anchorage assembly 210 supporting a structural element and comprising first and second anchor rods 212 in the foundation with a portion of each anchor rod extending out of the foundation, and a shear lug 202 comprising a first component including a hole receiving the first anchor rod to affix the first anchor rod directly to the shear lug 202, a second component extending from the first component at an angle down into the foundation, a third component including a hole receiving the second anchor rod to affix the second anchor rod directly to the shear lug, and a fourth component extending from the third component at an angle down into the foundation. The first component 202 has a first edge and a second edge opposite the first edge. The second component extends from the first component adjacent only one of the first and second edges of the first component. The third component has a third edge and a fourth edge opposite the third edge. The fourth component extends from the third component adjacent only one of the third and fourth edges of the third component. The second and fourth components are parallel to each other and affixed to each back to back. The second and fourth components transmit shear forces exerted on the first and second anchor rods by the structural element into the foundation.
Patent NZ-622432-A (NZ)
Title: Antimicrobial ionomer composition and uses thereof
Inventor: MÄKI MARKUS
IPC: A01N59/16
Filed: 2012-08-22
Abstract: The disclosure concerns a polymeric antimicrobial composition, a method of producing the same and the uses thereof. The ionomer composition comprises an amine functional polymer compound reacted with silver halide, optionally together with a stabilizing component, such as an organic substance carrying a sulfonamide functional group. The ionomer composition can be obtained by reacting together (i) at least one polyamine and silver halide and optionally at least one organic stabilizer substance or; (ii) at least one polyamine, at least one non-halide silver salt or silver complex, hydrogen halide and/or alkaline metal halide salt and optionally at least one organic stabilizer substance. The present ionomer composition is suitable for use as an antimicrobial coating, antimicrobial finish, antimicrobial additive and as antimicrobial component for formation of new antimicrobial materials.
Patent NZ-628664-A (NZ)
Title: Severe duty grapple with tubular pivot
Inventor: RAIHALA DANIEL J
IPC: F16C11/04
Filed: 2011-03-22
Abstract: A severe duty grapple (80), for attachment to the dipper stick of a backhoe, is disclosed. The severe duty grapple includes an upper jaw (82) and a lower jaw (100), where each jaw has a load engaging plate (87), an inner end (86, 104), and a first side and a second side. First and second lugs (107) each have an eyelet (108) which are fixed at the inner ends of one of the upper or lower jaws in spaced relation. A hollow tubular pivot (88) is provided at the inner end of the other one of the upper or lower jaws and is disposed between, and coaxial with, the eyelets of the first and second lugs. A singular pivot pin (110) extends through the eyelets of the first and second lugs and through the hollow tubular pivot such that upper and lower jaws are pivotal with respect to one another about the singular pivot pin. The inner end of the upper jaw and the inner end of the lower jaw are in proximity to one another, such that the inner ends together with the upper and lower load engaging plates define a closed throat, preventing debris from entering between the upper and lower jaws which could cause damage to the grapple during use.
Patent NZ-700314-A (NZ)
Title: Serine/threonine kinase inhibitors
Inventor: MORENO DAVID A
IPC: C07F9/6596
Filed: 2013-03-01
Abstract: Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Patent NZ-702259-A (NZ)
Title: Bent blade screw ground anchor
Inventor: LURKINS JOSEPH J
IPC: E21B10/44
Filed: 2014-11-24
Abstract: A ground anchor is provided for driving into hard or soft ground for anchoring or supporting a structure. The ground anchor includes a hub with a helical load bearing plate and a pointed ground engaging end having a body with a spade point blade extending axially from the body and the hub to assist in penetrating the ground and loosening the soil to allow the helical plate to penetrate the ground. The blade has first and second opposing spiral major faces and first and second transverse minor spiral faces that converge at a flat axial face to form the blade with a spiral configuration. The blade has a longitudinal dimension extending at an inclined angle with respect to a longitudinal center axis of the ground anchor so that the axial face of the blade is spaced outwardly from the center axis of the ground anchor. The leading edge of the spiral blade is oriented to direct the soil to the leading edge of the helical plate of the ground anchor.